JENNIFER SMOLENSKI: Open Payments
NPI 1770959223 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,413 in 218 payments from 18 companies in 2025. Trend: 2023 $2,954 · 2024 $2,958 · 2025 $3,413
Food & beverage: $3,413
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 38 | $741 |
| ABBVIE INC. | 41 | $611 |
| Takeda Pharmaceuticals U.S.A., Inc. | 33 | $455 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 20 | $276 |
| Aimmune Therapeutics, Inc. | 35 | $268 |
| Phathom Pharmaceuticals, Inc. | 7 | $188 |
| Madrigal Pharmaceuticals | 13 | $188 |
| PFIZER INC. | 5 | $121 |
| Intercept Pharmaceuticals, Inc. | 4 | $115 |
| Regeneron Healthcare Solutions, Inc. | 5 | $113 |
Products named: TREMFYA, ENTYVIO, XIFAXAN, RINVOQ, ZENPEP, SKYRIZI, VOQUEZNA, REZDIFFRA.
Industry payments across OH — which companies pay providers there.
